Patient and public involvement prior to trial initiation: lessons learnt for rapid partnership in the COVID-19 era.
Zahra JamalAlexander PerkinsChristopher Allennull nullRichard EvansJoanna SturgessClaire SnowdonTim ClaytonDiana ElbournePublished in: Research involvement and engagement (2021)
PPI for clinical trials can be conducted in a time-efficient manner within the pressured environment of a pandemic. Involving PPI contributors at an early stage in protocol development maximised the opportunity to shape and influence the trial as well as limited potential delays which could occur if changes to the protocol had to be made at a later stage.
Keyphrases
- clinical trial
- coronavirus disease
- sars cov
- early stage
- phase ii
- phase iii
- study protocol
- randomized controlled trial
- protein protein
- healthcare
- open label
- case report
- mental health
- small molecule
- respiratory syndrome coronavirus
- squamous cell carcinoma
- sentinel lymph node
- loop mediated isothermal amplification
- climate change
- sensitive detection